CEACAM5 and pancreatic neoplasm: Conventional serum tumour markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9), have been used for diagnostic assays (Satake et al, 1985) in the early detection and monitoring of pancreatic cancer.